Search results for "From ACP Hospitalist Weekly"
C. diff recurrence risk reduced with bezlotoxumab versus placebo, industry study finds
The number needed to treat to prevent one Clostridium difficile recurrence was 10 in the overall patient population and 6 in patients age 65 years and over and those with previous infections.
https://gastroenterology.acponline.org/archives/2017/02/24/6.htm
24 Feb 2017
Review finds benefit to early feeding for mild to moderate pancreatitis
The results support feeding acute pancreatitis patients sooner than recommended by current guidelines, according to the review authors, but an accompanying editorial urged caution in applying the research to practice.
https://gastroenterology.acponline.org/archives/2017/05/26/9.htm
26 May 2017
Facility-level antibiotic use associated with C. difficile rates in long-term care
Importation of Clostridium difficile was three times more common in long-term care than in acute care, leading the study authors to recommend better coordination of infection control across settings.
https://gastroenterology.acponline.org/archives/2017/06/23/7.htm
23 Jun 2017
Antibiotic stewardship programs reduce incidence of C. difficile, multidrug-resistant infections, review finds
The systematic review also found that antibiotic stewardship programs were significantly more effective when implemented along with infection control measures.
https://gastroenterology.acponline.org/archives/2017/07/28/12.htm
28 Jul 2017
Short course of antibiotics worked as well as long for Enterobacteriaceae bacteremia
Rates of mortality, recurrent bloodstream infections, and Clostridium difficile infections within 30 days were similar whether patients received eight or 15 days of antibiotics.
https://gastroenterology.acponline.org/archives/2017/10/27/9.htm
27 Oct 2017
H2 blockers prevented clinically important GI bleeding better than PPIs in ICU patients
The retrospective study included 70,093 ICU patients who had at least one risk factor for stress ulcers and therefore had received a proton-pump inhibitor (PPI) or histamine H2-receptor antagonist (H2 blocker) for three or more days.
https://gastroenterology.acponline.org/archives/2018/06/22/9.htm
22 Jun 2018
High inpatient occupancy levels associated with lower risk of hospital-acquired C. diff
Researchers analyzed administrative data from 2008 to 2012 among Medicare recipients with a discharge diagnosis of acute myocardial infarction, heart failure, or pneumonia at 327 California hospitals.
https://gastroenterology.acponline.org/archives/2018/07/27/8.htm
27 Jul 2018
Beta-blocker choice may affect outcomes in cirrhosis and acute MI
Patients who took beta1-selective blockers had fewer major cardiac and cerebrovascular events within two years of an index myocardial infarction (MI) than those taking nonselective beta-blockers, a Taiwanese study found.
https://gastroenterology.acponline.org/archives/2018/09/28/7.htm
28 Sep 2018
Study identifies potential predictors of hospital-onset C. difficile infection
In patients colonized with Clostridioides difficile, risk factors for infection included longer length of stay, exposure to multiple classes of antibiotics, use of opioids, and cirrhosis, whereas use of laxatives was associated with a lower risk.
https://gastroenterology.acponline.org/archives/2019/07/26/8.htm
26 Jul 2019
New international guideline updates recommendations on managing patients with nonvariceal GI bleeding
The new guideline is “a step forward,” particularly with regard to new endoscopic therapies and management of upper gastrointestinal (GI) bleeding in patients on antiplatelet or anticoagulant drugs, an editorial noted.
https://gastroenterology.acponline.org/archives/2019/10/25/6.htm
25 Oct 2019